Pro Medicus, Ltd. · ASX:PME
Pro Medicus — Shareholder Meeting (November 2010)
26 slides from Pro Medicus's shareholder meeting presentation, Nov 23, 2010
Slide 1: Annual General Meeting
For personal use only Annual General Meeting November 23rd 2010 Australia’s Leading HealthCare IT Company
Slide 2: Pro Medicus – Chairman
For personal use only PRO MEDICUS • Peter Kempen- Chairman
Slide 3: Board Members
Board Members For personal use only • Sam Hupert – CEO & Deputy Chairman • Anthony Hall – Executive Director • Peter Jonson – Non-Executive Director
Slide 4: Officers
Officers For personal use only • Clayton Hatch – Finance Manager/Company Secretary • Stuart Painter – Ernst and Young Auditor In absentia: • Danny Tauber – Chief Operating Officer • Malte Westerhoff – Managing Director (Visage - Germany) • John Danahy – National Business Manager (Visage - USA)
Slide 5: Pro Medicus – In Perspective
Pro Medicus – In Perspective For personal use only 4 • 2007/08 –Sustained profit growth and optimism re acquisition opportunity. • 2008/09 – A time of change facing the global financial crisis, and changes with overseas partner (Agfa) . Visage acquisition. • 2009/10 – A time of transition to a chall
Slide 6: Board Changes
Board Changes For personal use only • Mel Ward AO • David Chambers • Peter Jonson New Director • Rod Lyle
Slide 7: Pro Medicus – CEO
For personal use only PRO MEDICUS • Sam Hupert- CEO
Slide 8: Pro Medicus – Key milestones
Pro Medicus – Key milestones For personal use only 7 • Release of the Visage 7.0 platform • Right sizing of US operations • Significant progress with new RIS technology platform • Continued growth of Amira • 3 Key sales of Visage 7.0 in Australia • Increased brand awareness in US & Europe.
Slide 9: Pro Medicus – Integration
Pro Medicus – Integration For personal use only 8 • Alignment of R&D teams in Melbourne and Berlin • New management structure • Unified accounting and support systems • Flexibility to use resources across three continents
Slide 10: Pro Medicus – Visage 7.0
Pro Medicus – Visage 7.0 For personal use only 9 Previously • A niche market 3-D product • Addressed 5% to 10% of market Now • Unique 2-D/3-D thin client platform - Universal viewer • New generation 3-D PACS • Addresses up to 85% of market • Seen as technological leader • Strong competitive advantag
Slide 11: Pro Medicus – US Operations
Pro Medicus – US Operations For personal use only 10 • New general manager – 17 years industry experience • New offices based in San Diego • Right sizing of staff numbers • More experienced sales staff • Greater use of electronic marketing • Decreased operating costs by $1M per annum
Slide 12: Pro Medicus – “Coral”
Pro Medicus – “Coral” For personal use only 11 • Entirely new technology platform • 3 Years in development • Release in December/January time frame • Repositions company as clear technology leader • Reduced cost of ongoing development • More cost effective to support
Slide 13: “Coral” – everything is new!
“Coral” – everything is new ! For personal use only
Slide 14: Pro Medicus – Amira
Pro Medicus – Amira For personal use only 13 • 3D Toolkit for Life Sciences • Sold through Web Store • Sales still growing strongly - 15% plus pa • Increases awareness of Visage brand
Slide 15: Pro Medicus – Key Sales
Pro Medicus – Key Sales For personal use only 14 • 3 major sales of Visage 7.0 in Australia • Both new and existing clients • Helped develop new competencies • Forms base for future referral
Slide 16: Pro Medicus – Marketing
Pro Medicus – Marketing For personal use only 15 • Electronic marketing successful • Leverages technology advantage • Validated by recent Frost and Sullivan award • Increased lead generation
Slide 17: RSNA Ad Campaign – Visage
RSNA Ad Campaign – Visage 7 For personal use only Now Apple Healthcare Innovation MAC of the Year Award Compatible
Slide 18: Pro Medicus, now truly global…
Pro Medicus, now truly global… For personal use only A Full Suite of Enterprise PACS/RIS/Visualization and E:Health Business Software Solutions • Visage 7.0 - 3D PACS & Universal Viewer • New Technology RIS Platform – “Coral” • 70 employees, in three centers (US, Germany and Australia) • ISO 9001 +
Slide 19: 2010/11 1st half to date
2010/11 1st half to date For personal use only • Consolidation period for new technology • Australian market affected by government changes • “Headwind” from adverse currency impact. • Increase in US and European opportunities • Momentum expected to build into the 2nd half
Slide 20: Opportunities
Opportunities For personal use only • Greater penetration of US markets • Up-selling opportunities for Australian business • Public hospitals both here and overseas • New dealer channels and “pay per view” revenue streams. • Push into Europe – particularly UK
Slide 21: 2010/11 Financial Outlook
2010/11 Financial Outlook For personal use only • Increased benefits to flow from Visage acquisition • Technology value proposition to drive higher margins • Continued investment in product development. • Increased percentage of revenue from offshore • Currency impact may remain an issue • 2nd half
Slide 22: Growth strategies for 2010/2011
Growth strategies for 2010/2011 For personal use only 21 US and European New sales expansion channels Expanded Visage Imaging – product portfolio Promedicus continuing integration New (RIS) Penetrate technology platform hospital market
Slide 23: For personal use only
For personal use only • Investments in R&D bearing fruit with milestones met for new technology platform. • Ongoing investment in new people and infrastructure. Underpins future by transitioning products to new technology platform. • Increasing our presence and skills in North America. • Established
Slide 24: PROMEDICUS – Thanks
For personal use only PROMEDICUS • My thanks to Directors for their strong contribution • Thanks to our management and staff for their innovative creativity and hard work.
Slide 25: Resolution of Shareholders
RESOLUTION OF SHAREHOLDERS For personal use only • Resolution 2 – To adopt the Remuneration Report (non binding) FOR OPEN AGAINST 67,746,792 194,035 14,070,197 82.61% 0.24% 17.15%
Slide 26: Resolution of Shareholders
RESOLUTION OF SHAREHOLDERS For personal use only • Resolution 3B – To elect as a Director Anthony Hall FOR OPEN AGAINST 51,713,584 204,035 51,752 99.51% 0.39% 0.10%